1.
Chembiochem
; 14(13): 1548-51, 2013 Sep 02.
Artículo
en Inglés
| MEDLINE
| ID: mdl-23939727
2.
Org Lett
; 15(7): 1678-81, 2013 Apr 05.
Artículo
en Inglés
| MEDLINE
| ID: mdl-23521145
RESUMEN
A mutasynthetic strategy has been used to generate fluorinated TM-025 and TM-026, two biosynthetically engineered pactamycin analogues produced by Streptomyces pactum ATCC 27456. The fluorinated compounds maintain excellent activity and selectivity toward chloroquine-sensitive and multidrug-resistant strains of malarial parasites as the parent compounds. The results also provide insights into the biosynthesis of 3-aminobenzoic acid in S. pactum.